M LH1
Pill imprint M LH1 has been identified as Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg.
Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy.
Hydrochlorothiazide/lisinopril 12.5 mg / 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Hydrochlorothiazide and lisinopril Images
- Imprint:
-
M
LH1 - Strength:
- 12.5 mg / 10 mg
- Color:
- White
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
microcrystalline cellulose
povidone
corn starch
sodium lauryl sulfate
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-1012
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0697 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
Advertisement
More Hydrochlorothiazide and Lisinopril resources
- Lisinopril/Hydrochlorothiazide (Wolters Kluwer)
- hydrochlorothiazide and lisinopril (Cerner Multum)
- lisinopril and hydrochlorothiazide (Micromedex) - Includes Dosage Information
- Lisinopril and Hydrochlorothiazide (FDA)
- Lisinopril/Hydrochlorothiazide (Wolters Kluwer)
Search Again
